We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns AngioDynamics Unit Over Hair in Sterile Product
FDA Warns AngioDynamics Unit Over Hair in Sterile Product
January 13, 2015
AngioDynamics subsidiary Navilyst Medical received an FDA warning letter for quality issues at two manufacturing facilities, including the sale of sterile product that contained foreign matter such as hair.